3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Marijuana Abuse
2
Breast Neoplasms
2
Anxiety Disorders
2
Sturge-Weber Syndrome
1
Solid Tumor
1
Prostatic Neoplasms
1
Parasomnias
1
Pain
1
Nausea
1
Glioblastoma
1
Colonic Neoplasms
1
Cognitive Dysfunction
1
Chemotherapy-Induced Peripheral Neuropathy
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Cancer Pain
1
Breast Carcinoma In Situ
1
Arthralgia
1
Interventions
Morphine
2
resiniferatoxin
1
incobotulinumtoxinA
1
fulranumab
1
cannabichromene
1
alvimopan
1
Tablets
1
Surveys and Questionnaires
1
Standard of Care
1
Pain Management
1
Oxycodone
1
Occupational Therapy
1
Massage
1
Lidocaine
1
Lenalidomide
1
Ketamine
1
Gels
1
Fentanyl
1
Dronabinol
1
Cannabidiol
1
Animal Assisted Therapy
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Cancer Pain
×
Cannabidiol
×
Clear all
NCT06533657
2026-04-21
UTOPIA-1
ZYUS Life Sciences Inc.
Phase 2
Completed
11 enrolled